Covid-19: Covaxin trial starts today; Russia denies UK's hacking claims
Covaxin is an indigenously developed Covid-19 vaccine candidate, developed by a Hyderabad-based Bharat Biotech in collaboration with ICMR and NIV
Kanishka Gupta New Delhi
 "Coronavirus")
Living with a pandemic could be more difficult especially when we are not updated with the latest developments.
In this edition of Business Standard podcast, we will cover major coronavirus-related developments of the past 24 hours.
In this edition of Business Standard podcast, we will cover major coronavirus-related developments of the past 24 hours.
Click podcast for more
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 20 2020 | 1:12 PM IST
